PortfoliosLab logoPortfoliosLab logo
NUS vs. FRD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NUS vs. FRD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nu Skin Enterprises, Inc. (NUS) and Friedman Industries, Incorporated (FRD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NUS achieves a -43.75% return, which is significantly lower than FRD's 19.41% return. Over the past 10 years, NUS has underperformed FRD with an annualized return of -15.93%, while FRD has yielded a comparatively higher 16.43% annualized return.


NUS

1D
0.76%
1M
-26.69%
YTD
-43.75%
6M
-44.84%
1Y
-30.58%
3Y*
-44.03%
5Y*
-36.38%
10Y*
-15.93%

FRD

1D
2.01%
1M
16.66%
YTD
19.41%
6M
24.71%
1Y
46.14%
3Y*
37.81%
5Y*
12.57%
10Y*
16.43%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NUS vs. FRD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NUS
Nu Skin Enterprises, Inc.
-43.75%43.29%-63.67%-51.07%-13.92%-4.32%38.67%-30.98%-8.32%46.55%
FRD
Friedman Industries, Incorporated
19.41%35.33%-0.26%58.98%5.34%37.91%15.73%-12.71%26.02%-14.17%

Correlation

The correlation between NUS and FRD is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Nov 25, 1996

0.10

The correlation between NUS and FRD shifts across timeframes, from 0.10 (all time) to 0.28 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

EPS

NUS:

$1.10

FRD:

$3.57

PE Ratio

NUS:

4.86

FRD:

6.82

PS Ratio

NUS:

0.18

FRD:

0.19

Total Revenue (TTM)

NUS:

$1.44B

FRD:

$584.35M

Gross Profit (TTM)

NUS:

$998.90M

FRD:

$38.95M

EBITDA (TTM)

NUS:

$115.40M

FRD:

$26.21M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NUS vs. FRD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUS
NUS Risk / Return Rank: 1919
Overall Rank
NUS Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
NUS Sortino Ratio Rank: 1818
Sortino Ratio Rank
NUS Omega Ratio Rank: 1818
Omega Ratio Rank
NUS Calmar Ratio Rank: 2323
Calmar Ratio Rank
NUS Martin Ratio Rank: 1717
Martin Ratio Rank

FRD
FRD Risk / Return Rank: 7171
Overall Rank
FRD Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
FRD Sortino Ratio Rank: 7171
Sortino Ratio Rank
FRD Omega Ratio Rank: 6767
Omega Ratio Rank
FRD Calmar Ratio Rank: 7373
Calmar Ratio Rank
FRD Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NUS vs. FRD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nu Skin Enterprises, Inc. (NUS) and Friedman Industries, Incorporated (FRD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NUSFRDDifference
Sharpe ratioReturn per unit of total volatility

-1.62

Sortino ratioReturn per unit of downside risk

-2.32

Omega ratioGain probability vs. loss probability

0.92

1.21

-0.28

Calmar ratioReturn relative to maximum drawdown

-0.53

1.87

-2.40

Martin ratioReturn relative to average drawdown

-1.13

4.01

-5.14

NUS vs. FRD - Sharpe Ratio Comparison

The current NUS Sharpe Ratio is -0.58, which is lower than the FRD Sharpe Ratio of 1.04. The chart below compares the historical Sharpe Ratios of NUS and FRD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NUSFRDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.58

1.04

-1.62

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.78

0.24

-1.02

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.33

0.34

-0.66

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

0.23

-0.30

Drawdowns

NUS vs. FRD - Drawdown Comparison

The maximum NUS drawdown since its inception was -94.30%, which is greater than FRD's maximum drawdown of -71.00%. Use the drawdown chart below to compare losses from any high point for NUS and FRD.


Loading charts...

Drawdown Indicators


NUSFRDDifference

Max Drawdown

Largest peak-to-trough decline

-94.30%

-71.00%

-23.30%

Max Drawdown (1Y)

Largest decline over 1 year

-57.93%

-24.77%

-33.16%

Max Drawdown (3Y)

Largest decline over 3 years

-83.43%

-46.49%

-36.94%

Max Drawdown (5Y)

Largest decline over 5 years

-89.89%

-53.55%

-36.34%

Max Drawdown (10Y)

Largest decline over 10 years

-91.91%

-65.09%

-26.82%

Current Drawdown

Current decline from peak

-94.26%

-0.04%

-94.22%

Average Drawdown

Average peak-to-trough decline

-48.07%

-34.73%

-13.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.10%

11.53%

+15.57%

Volatility

NUS vs. FRD - Volatility Comparison

Nu Skin Enterprises, Inc. (NUS) and Friedman Industries, Incorporated (FRD) have volatilities of 12.63% and 12.99%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NUSFRDDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.63%

12.99%

-0.36%

Volatility (6M)

Calculated over the trailing 6-month period

33.53%

28.16%

+5.37%

Volatility (1Y)

Calculated over the trailing 1-year period

53.23%

44.57%

+8.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

47.01%

52.31%

-5.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.14%

48.58%

+0.56%

Dividends

NUS vs. FRD - Dividend Comparison

NUS's dividend yield for the trailing twelve months is around 4.51%, more than FRD's 0.66% yield.


PositionTTM20252024202320222021202020192018201720162015
FRD
Friedman Industries, Incorporated
0.66%0.78%0.92%0.52%0.82%0.85%1.17%2.66%1.70%0.70%0.60%0.90%
NUS
Nu Skin Enterprises, Inc.
4.51%2.49%3.48%8.03%3.65%3.00%2.75%3.61%2.38%2.11%2.97%3.69%

Financials

NUS vs. FRD - Financials Comparison

This section allows you to compare key financial metrics between Nu Skin Enterprises, Inc. and Friedman Industries, Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
320.61M
167.97M
(NUS) Total Revenue
(FRD) Total Revenue
Values in USD except per share items

NUS vs. FRD - Profitability Comparison

The chart below illustrates the profitability comparison between Nu Skin Enterprises, Inc. and Friedman Industries, Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
66.9%
0
Portfolio components
NUS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported a gross profit of 214.46M and revenue of 320.61M. Therefore, the gross margin over that period was 66.9%.

FRD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Friedman Industries, Incorporated reported a gross profit of 0.00 and revenue of 167.97M. Therefore, the gross margin over that period was 0.0%.

NUS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported an operating income of 4.03M and revenue of 320.61M, resulting in an operating margin of 1.3%.

FRD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Friedman Industries, Incorporated reported an operating income of 3.90M and revenue of 167.97M, resulting in an operating margin of 2.3%.

NUS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported a net income of 1.84M and revenue of 320.61M, resulting in a net margin of 0.6%.

FRD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Friedman Industries, Incorporated reported a net income of 4.00M and revenue of 167.97M, resulting in a net margin of 2.4%.


Frequently Asked Questions


NUS and FRD have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FRD has higher volatility (12.99%) compared to NUS (12.63%). In terms of maximum drawdown, NUS dropped -94.30% vs FRD's -71.00%.

FRD currently has the higher Sharpe Ratio (1.04 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NUS and FRD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer